Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

News > All

Total search results: 17065 | Ordered by Date (descending)
1 2 3 ... 169 170 171  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Medicines Discovery Catapult, The. (9/19/18). "Press Release: Novel Deep Learning Drug Discovery Platform Gets £1 Million Innovation boost. Optibrium, Intellegens and Medicines Discovery Catapult Awarded Funding to Apply Machine Learning in Drug Discover 2018-09-19
Apeiron Biologics AG. (9/19/18). "Press Release: Apeiron Announces Collaboration with Lead Discovery Center GmbH". Vienna. 2018-09-19
Premaitha Health plc. (9/19/18). "Press Release: Legal Settlement and Licence Agreement with Illumina". Manchester. 2018-09-19
Argen-X N.V. (Argenx). (9/19/18). "Press Release: Argenx Raises approximately $300.6 Million in Gross Proceeds in a U.S. Public Offering". Breda & Ghent. 2018-09-19
GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. 2018-09-18
Horama S.A.. (9/18/18). "Press Release: Horama Completes Its 22.5 Million Euros Series B Financing Round". Paris. 2018-09-18
BRAIN AG. (9/18/18). "Press Release: BRAIN AG Announces Strategic Research Collaboration with BluCon Biotech GmbH". Zwingenberg & Cologne. 2018-09-18
Neurimmune AG. (9/18/18). "Press Release: Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical". Schlieren. 2018-09-18
Argen-X N.V. (Argenx). (9/17/18). "Press Release: Argenx Announces Launch of Proposed Public Offering in the United States". Breda & Ghent. 2018-09-17
GamaMabs Pharma S.A.. (9/17/18). "Press Release: GamaMabs Pharma Starts a Phase 2 Study of Monoclonal Antibody GM102 in Patients with Advanced or Metastatic Colorectal Cancer". Paris & Toulouse. 2018-09-17
CRISPR Therapeutics AG. (9/17/18). "Press Release: CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes". Zug, Cambridge, MA & San Diego, CA. 2018-09-17
Qiagen N.V.. (9/17/18). "Press Release: Qiagen and DiaSorin Launch Automated Testing for Latent TB Infection with QuantiFERON-TB Gold Plus Technology on Widely Used Liaison Platforms". Hilden & Saluggia. 2018-09-17
Argen-X N.V. (Argenx). (9/17/18). "Press Release: Argenx Reports Positive Topline Results from Phase 2 Proof-of-Concept Trial of Efgartigimod in Primary Immune Thrombocytopenia". Breda & Ghent. 2018-09-17
Cancer Research UK. (9/17/18). "Press Release: London Biotherapeutics Powerhouse Launched by Cancer Research UK". 2018-09-17
Sphere Fluidics Ltd.. (9/17/18). "Press Release: Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite". Cambridge. 2018-09-17
Qiagen N.V.. (9/17/18). "Press Release: Qiagen and NeuMoDx Announce Strategic Partnership to Offer Next-generation Systems for Fully Integrated Molecular Diagnostic Testing". Hilden & Ann Arbor, MI. 2018-09-17
Metrion Biosciences Ltd.. (9/17/18). "Press Release: Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership tTeam". Cambridge. 2018-09-17
BIA Separations d.o.o.. (9/17/18). "Press Release: BIA Separations Expands with New Upstream Processing Facility". Ajdovšcina. 2018-09-17
Evotec AG. (9/17/18). "Press Release: Evotec and Almirall Enter into Research Collaboration in the Field of Dermatiological Diseases". Hamburg & Barcelona. 2018-09-17
Sanofi S.A.. (9/15/18). "Press Release: Positive Phase 3 Results Presented for Dupixent (dupilumab) Show Significant Improvement on Multiple Measures of Disease Severity in Adolescents with Moderate-to-Severe Atopic Dermatitis". Paris & Tarrytown, NY. 2018-09-15
Horizon Discovery Group plc. (9/14/18). "Press Release: Horizon Discovery Edit-R crRNA Libraries Adopted by AstraZeneca as Part of Its Functional Genomics Discovery Platform". Cambridge. 2018-09-14
MorphoSys AG. (9/13/18). "Press Release: MorphoSys and Galapagos Announce Start of a Phase 1 Subcutaneous Bridging Study with MOR106". Planegg & Mechelen. 2018-09-13
ViraTherapeutics GmbH. (9/13/18). "Press Release: Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies". Ingelheim. 2018-09-13
Galapagos N.V.. (9/13/18). "Press Release: Galapagos Raises $300 Million Gross Proceeds in a U.S. Public Offering". Mechelen. 2018-09-13
Targovax ASA. (9/13/18). "Press Release: Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO". Oslo. 2018-09-13
Wacker Chemie AG. (9/13/18). "Press Release: Wacker Invests in Jena Biotech Site". Jena. 2018-09-13
Sanofi S.A.. (9/13/18). "Press Release: Sanofi to Refocus Two Global Business Units". Paris. 2018-09-13
Neurimmune AG. (9/12/18). "Press Release: Neurimmune Appoints Christoph Hock as Chief Medical Officer to Lead Clinical Development". Schlieren. 2018-09-12
Boehringer Ingelheim. (9/12/18). "Press Release: Biosimilar Cyltezo Demonstrates Clinical equivalence to Humira® in Patients with Moderate-to-Severe Plaque Psoriasis". Ingelheim. 2018-09-12
University of Oxford. (9/12/18). "Press Release: Novo Nordisk Research Centre Opens in Oxford". 2018-09-12
Qiagen N.V.. (9/12/18). "Press Release: Qiagen to Join Germany’s MDAX Index in Addition to TecDAX". Hilden & Germantown, MD. 2018-09-12
Galapagos N.V.. (9/12/18). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen. 2018-09-12
University of Glasgow. (9/11/18). "Press Release: Cutting-edge Electron Microscope Revealed at Opening of New £5m Structural Biology Centre". 2018-09-11
Neovacs S.A.. (9/11/18). "Press Release: Neovacs Announces that Its Partner Biosense Global Has Exercised Its Option to Acquire the Exclusive Licence for IFNalpha Kinoid to Treat Lupus in China". Paris & Boston, MA. 2018-09-11
European Commission. (9/11/18). "Press Release: European List of Strategic Research infrastructures Expands into New Areas". Vienna. 2018-09-11
Optibrium Ltd.. (9/11/18). "Press Release: Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery". Cambridge. 2018-09-11
Cell and Gene Therapy Catapult, The. (9/11/18). "Press Release: Stevenage Cell and Gene Therapy Catapult Centre Gets Green Light to Make New Cell and Gene Therapies". 2018-09-11
MolMed S.p.A.. (9/11/18). "Press Release: MolMed Appoints Mr. Salvatore Calabrese Chief Financial Officer". Milan. 2018-09-11
Galapagos N.V.. (9/11/18). "Press Release: Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis". Foster City, CA & Mechelen. 2018-09-11
Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. 2018-09-11
F-Star Biotechnology Ltd.. (9/10/18). "Press Release: F-star Appoints Nessan Bermingham as Chairman of its Board of Directors". Cambridge. 2018-09-10
Fluidigm Corporation. (9/10/18). "Press Release: Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis". South San Francisco, CA. 2018-09-10
Arecor Ltd.. (9/10/18). "Press Release: Arecor Secures £6m Investment for the Clinical Development of Its Diabetes Speciality Pharma Portfolio". Cambridge. 2018-09-10
Definiens AG. (9/10/18). "Press Release: Definiens Embarks on Digital Pathology Collaboration with Merck's Exploratory and Clinical Development Programs". Munich. 2018-09-10
RSP Systems A/S. (9/10/18). "Press Release: RSP Systems Adds EUR 3.85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10.35 Million". Odense. 2018-09-10
Haplogen Bioscience GmbH. (9/10/18). "Press Release: Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases". Montréal, QC & Vienna. 2018-09-10
Ilya Pharma AB. (9/10/18). "Press Release: Ilya Pharma Raises Additional Euro 3 Million to Take Novel ATMP through to Phase II for Wound Care". 2018-09-10
Pieris Pharmaceuticals, Inc.. (9/10/18). "Press Release: Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil., to its Board of Directors". Boston, MA. 2018-09-10
Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. 2018-09-09
BTG plc. (9/7/18). "Press Release: BTG plc Acquires Novate Medical Ltd.". 2018-09-07
European Invesmtent Bank (EIB). (9/7/18). "Press Release: Investment Plan for Europe – the EIB and Grifols Sign a New Loan Agreement to Advance Research on Rare and Chronic Diseases". 2018-09-07
Visiopharm A/S. (9/7/18). "Press Release: Launching Phenomap Multiplexing". 2018-09-07
Argen-X N.V. (Argenx). (9/6/18). "Press Release: Argenx Doses First Patient in Global Phase 3 Registration Trial of Efgartigimod". Breda & Ghent. 2018-09-06
MorphoSys AG. (9/6/18). "Press Release: MorphoSys AG to Be Listed in MDAX". Planegg. 2018-09-06
Devicare S.L.. (9/6/18). "Press Release: Devicare Gets the Patent for Its Sensor Technology in Europe and USA". 2018-09-06
Evotec AG. (9/6/18). "Press Release: Evotec AG Listed in MDAX". Hamburg. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Novo Holdings Invests CHF 6.8 Million in Polyphor to Accelerate the Development of Novel Antibiotics against Multi-drug Resistant Gram-negative Pathogens". Allschwil & Copenhagen. 2018-09-06
Medigene AG. (9/6/18). "Press Release: Medigene Announces Inclusion in SDAX". Planegg. 2018-09-06
Evotec AG. (9/6/18). "Press Release: Evotec and Celgene Enter Partnership in the Field of Targeted Protein Degradation". Hamburg. 2018-09-06
Novartis AG. (9/6/18). "Press Release: Novartis to Divest the Sandoz US Dermatology Business and Generic US Oral Solids Portfolio to Aurobindo". Basel. 2018-09-06
Allogene Therapeutics, Inc.. (9/6/18). "Press Release: Allogene Therapeutics Completes a $120 Million Private Financing". South San Francisco, CA. 2018-09-06
Adocia S.A.. (9/5/18). "Press Release: Adocia Announces Positive Topline Results for the First Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-09-05
Adaptimmune Therapeutics plc. (9/5/18). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2018-09-05
Azeria Therapeutics Ltd.. (9/4/18). "Press Release: Azeria Therapeutics, the World's First Pioneer Factor Drug Discovery Company, Announces Series A Investment from Sixth Element Capital". Cambridge. 2018-09-04
Probiodrug AG. (9/4/18). "Press Release: Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy". Halle (Saale). 2018-09-04
Eurofins. (9/4/18). "Press Release: Eurofins Expands Its Leading Global Cosmetic Testing Footprint with the Acquisition of Clinical Research Laboratories in North America". 2018-09-04
NTrans Technologies B.V.. (9/4/18). "Press Release: NTrans Technologies Receives Horizon 2020 SME Grant". 2018-09-04
Arix Bioscience plc. (9/4/18). "Press Release: Changes Announced to Executive Team to Accelerate Growth and Strategy". London. 2018-09-04
Sanofi S.A.. (9/4/18). "Press Release: Sanofi Reaches Civil Settlement with US SEC". Paris. 2018-09-04
Miracor Medical S.A.. (9/4/18). "Press Release: Miracor Medical Closes Final Tranche of Series D, Bringing the Round to €30M". Awans. 2018-09-04
Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev. 2018-09-04
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA. 2018-09-04
Sanofi S.A.. (9/3/18). "Press Release: Cablivi (caplacizumab) Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2018-09-03
Evox Therapeutics Ltd.. (9/3/18). "Press Release: Evox Therapeutics Completes £35.5 Million Series B Financing". Oxford. 2018-09-03
AiCuris Anti-infective Cures GmbH. (9/3/18). "Press Release: AiCuris Reports Positive Phase 1 Clinical Trial Results with Immunomodulator AIC649 in Patients with Chronic Hepatitis B". Wuppertal. 2018-09-03
EuropaBio. (9/3/18). "Press Release: EuropaBio Appoints New Secretary General, Healthcare Director and Industrial Biotech Director". Brussels. 2018-09-03
Tecan Group Ltd.. (9/3/18). "Press Release: Tecan Successfully Completes the Acquisition of NuGen Technologies". Männedorf. 2018-09-03
Boehringer Ingelheim. (9/3/18). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Supports BeiGene in Its China NDA Submission of anti-PD-1 Antibody, Tislelizumab". Shanghai. 2018-09-03
BRAIN AG. (8/31/18). "Press Release: BRAIN AG Reports Growth for the First Nine Months of the 2017/18 Financial Year". Zwingenberg. 2018-08-31
Medigene AG. (8/31/18). "Press Release: Medigene Announces Change in Executive Leadership Team". Planegg. 2018-08-31
EMD Serono. (8/31/18). "Press Release: Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America". Rockland, MA. 2018-08-31
Novartis Pharma GmbH. (8/31/18). "Pressemitteilung: Novartis und das Fraunhofer IZI geben Kooperation in der CAR-T Zelltherapie für Patienten in Europa bekannt". Leipzig & Nürnberg. 2018-08-31
BRAIN AG. (8/30/18). "Press Release: DOLCE Core Team Announces Membership Changes in Programme for Natural-based Sweeteners". Zwingenberg. 2018-08-30
Adocia S.A.. (8/30/18). "Press Release: Adocia Announces Update to Second Arbitration Against Eli Lilly & Company". Lyon. 2018-08-30
Genomics Medicine Ireland Ltd.. (8/30/18). "Press Release: Genomics Medicine Ireland and University of Cambridge Announce Multiple Sclerosis Research Collaboration". Dublin. 2018-08-30
EBD Group. (8/30/18). "Press Release: Global Life Sciences to Convene in Copenhagen for Europe's Largest Annual Biopharma Partnering Conference". Carlsbad, CA & Copenhagen. 2018-08-30
Genomics plc. (8/30/18). "Press Release: Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines". Boston, MA & Oxford. 2018-08-30
Immuneed AB. (8/30/18). "Press Release: Ultimovacs Acquires the Immunotherapy Technology Business of Immuneed AB for NOK 50 Million". 2018-08-30
Lunaphore Technologies S.A.. (8/30/18). "Press Release: Lunaphore Closes a CHF 5.3M Series B Financing Round". Lausanne. 2018-08-30
CiToxLab S.A.. (8/30/18). "Press Release: CiToxLab Appoints Christophe Berthoux as CEO, Europe". Evreux. 2018-08-30
GlaxoSmithKline plc. (8/30/18). "Press Release: European Commission Approves Nucala (mepolizumab) for the Treatment of Children with Severe Asthma". London. 2018-08-30
Alnylam Pharmaceuticals, Inc.. (8/30/18). "Press Release: Alnylam Receives Approval of Onpattro (patisiran) in Europe". Cambridge, MA. 2018-08-30
Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford. 2018-08-30
Bayer AG. (8/30/18). "Press Release: Bayer Receives US Approval for Modern Hemophilia A Treatment Jivi with a Step-wise Prophylaxis Dosing Regimen [Not intended for U.S. and UK Media]". Berlin. 2018-08-30
Probiodrug AG. (8/30/18). "Press Release: Probiodrug Reports Financial Results for H1 2018 and Corporate Update". Halle (Saale). 2018-08-30
Enzymicals AG. (8/30/18). "Press Release: Enzymicals AG Extends Its Capacity in Business Development". 2018-08-30
Evotec AG. (8/30/18). "Press Release: Evotec and CHDI Foundation Extend Ongoing Collaboration to Fight Huntington’s Disease". Hamburg. 2018-08-30
BMBF. (8/29/18). "Pressemitteilung: Startschuss für Agentur zur Förderung von Sprunginnovationen". 2018-08-29
1 2 3 ... 169 170 171  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x102px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px

» top